BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220602T132000
DTEND;TZID=America/New_York:20220602T154500
DTSTAMP:20220601T173444Z
CREATED:20220601T173444Z
LAST-MODIFIED:20220601T173444Z
UID:55587-1654176000-1654184700@globalbiodefense.com
SUMMARY:Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape
DESCRIPTION:The National Academies’ Board on Life Sciences is pleased to present two discussions – Bioeconomy of the Future and Changing Landscape of Life Science Research Laboratories – to explore critical and emerging issues with the bioeconomy and privately-sponsored basic life sciences research. \nThe life sciences research landscape is changing rapidly as new investments in the bioeconomy drive convergence among science and technology fields to develop new products and services\, and as basic research laboratories are established by private investors. \nThe Bioeconomy of the Future will explore: \n\nChanges that have taken place since publication of the National Bioeconomy Blueprint (2012)\, Safeguarding the Bioeconomy (2020)\, and The Bio Revolution: Innovations Transforming Economies\, Societies\, and our Lives (2020)\nImmediate and near-term developments associated with the bioeconomy\nFuture needs for realizing the full potential of the bioeconomy\nOutstanding needs for protecting and promoting the bioeconomy long-term\n\nFeatured Speakers \n\nMary Maxon\, Schmidt Futures\nAndrea Hodgson\, Schmidt Futures\nMichael Chui\, McKinsey & Company\n\nThe Changing Landscape of Life Sciences Research Laboratories will explore: \n\nShifts in the landscape of life sciences research based on the emergence of research institutes funded by for-profit companies\nThe benefits to the shifting life sciences research landscape\nPossible trade-offs related to life sciences research that are conducted at for-profit institutions\nEmerging trends in life science research landscape and how they relate to current and future public policy\nFuture workforce needs and how education might change to support these new institutions\n\nPlease visit the National Academies’ Future Trends in the Bioeconomy and Changing Life Sciences Research Landscape event page for more information.
URL:https://globalbiodefense.com/event/future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://www.nationalacademies.org/event/06-02-2022/board-on-life-sciences-open-webinar-future-trends-in-the-bioeconomy-and-changing-life-sciences-research-landscape
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220608T180000
DTEND;TZID=America/New_York:20220608T180000
DTSTAMP:20220527T184920Z
CREATED:20220527T184920Z
LAST-MODIFIED:20220527T184920Z
UID:55106-1654711200-1654711200@globalbiodefense.com
SUMMARY:GMU Schar School of Policy and Government Virtual Open House
DESCRIPTION:The George Mason University (GMU) Schar School of Policy and Government will host a Master’s and Certificate Virtual Open House on June 8\, 2022 from 6:00 pm – 8:00 pm. \nThe event will provide an overview of available master’s degree programs and highlight GMU’s world-class faculty and research. Admissions and student services staff will be on hand to answer questions. \nThis event is the perfect opportunity to: \n\nExplore Schar School’s top-ranked master’s degree and graduate certificate programs\nLearn about your program of interest in depth\, including the curriculum\, admissions requirements\, and career opportunities\nAsk admissions team members specific questions about the application process\n\nBreakout sessions hosted by program directors and faculty will be available based on your primary program of interest: \nMaster’s in Biodefense\nMaster’s in International Commerce and Policy\nMaster’s in International Security\nMaster’s in Organization Development and Knowledge Management\nMaster’s in Political Science\nMaster’s in Public Administration (MPA)\nMaster’s in Public Policy (MPP) \nBiodefense Certificate\nEmergency Management and Homeland Security Certificate\nGlobal Health and Security Certificate\nIllicit Trade Analysis Certificate\nNational Security and Public Policy Certificate\nNonprofit Management Certificate\nPublic Management Certificate\nScience\, Technology\, and Security Certificate\nStrategic Trade Certificate\nTerrorism and Homeland Security Certificate \nFind more information and register to attend here. \nGlobal Biodefense is an official media partner of the GMU Schar School Biodefense program.
URL:https://globalbiodefense.com/event/gmu-schar-school-of-policy-and-government-virtual-open-house/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2022/05/schar-school-open-house-june-2022.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220614T083000
DTEND;TZID=America/New_York:20220614T170000
DTSTAMP:20220527T205853Z
CREATED:20220527T205356Z
LAST-MODIFIED:20220527T205853Z
UID:55113-1655195400-1655226000@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Moderna Pediatric (Ages 6-17) mRNA Vaccine EAU
DESCRIPTION:The VRBPAC committee will meet in open session on June 14\, 2022 to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904 \nOn June 15\, 2022\, under Topic II\, the committee will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \n  \n  \n 
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-moderna-pediatric-ages-6-17-mrna-vaccine-eau/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=GbNpaZeDPiA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220615T083000
DTEND;TZID=America/New_York:20220615T170000
DTSTAMP:20220527T210409Z
CREATED:20220527T210409Z
LAST-MODIFIED:20220527T210409Z
UID:55115-1655281800-1655312400@globalbiodefense.com
SUMMARY:VRBPAC Meeting to Review Pediatric (Infant - 5 Years) mRNA Vaccines
DESCRIPTION:The VRBPAC will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 5 years of age\, and also to discuss amending the EUA of the Pfizer-BioNTech COVID-19 mRNA vaccine to include the administration of the primary series to infants and children 6 months through 4 years of age. \nFDA intends to make background material available to the public no later than 2 business days before the meeting.  If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. The Docket Number is FDA-2022-N-0904.
URL:https://globalbiodefense.com/event/vrbpac-meeting-to-review-pediatric-infant-5-years-mrna-vaccines/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=Ixm4UmldTGQ
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220628T083000
DTEND;TZID=America/New_York:20220628T170000
DTSTAMP:20220527T213139Z
CREATED:20220527T213139Z
LAST-MODIFIED:20220527T213139Z
UID:55118-1656405000-1656435600@globalbiodefense.com
SUMMARY:VRBPAC Meeting on COVID-19 Vaccine Strain Composition Decisions
DESCRIPTION:The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. FDA is establishing a docket for public comment on this meeting. \nThe Docket Number is FDA-2022-N-0905
URL:https://globalbiodefense.com/event/vrbpac-meeting-on-covid-19-vaccine-strain-composition-decisions/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://www.youtube.com/watch?v=BFdzNUus_CE
END:VEVENT
END:VCALENDAR